Abstract: An antibody that specifically binds to ErbB3 or an antigen-binding fragment thereof, and use thereof, are provided. The antibody that specifically binds to ErbB3 or an antigen-binding fragment thereof may be effectively used to prevent or treat a disease related to activation or overexpression of ErbB3 protein.

Abstract: The application discloses a method of preventing immune cells from binding to other cells, which includes contacting the immune cells and the other cells with a composition comprising Bst2 antagonist.

Abstract: The application disclose a method of preventing immune cells from binding to other cells, which includes contacting the immune cells and the other cells with a composition comprising Bst2 antagonist.

Abstract: The present invention relates to a method for synthesizing a protein in a cell-free synthesis system, which comprises the steps of: (a) amplifying a DNA molecule encoding the protein to prepare linear DNA molecules with a stem and loop sequence at their terminus, wherein the stem and loop sequence comprises a nucleotide sequence inducing the formation of a stem and loop structure at the 3?-end of transcripts of the amplified DNA molecules to prevent degradation of the transcripts; and (b) contacting the amplified DNA molecules to a lysate of cells with deficient endoribonuclease E activity, thereby producing the protein in the cell-free synthesis system.